Dear readers, Just having returned from a particularly exhilarating annual ASCO meeting, I wanted to quickly share some of the most exciting results from the sarcoma sessions with all of you. Overall, this year revealed exciting advances in treatment of desmoid tumors, as well as PVNS. Additionally, we learned some important information about oral chemotherapy … More ASCO 2018 Updates for Sarcomas
Greetings, and humble apologies for the hiatus of this blog – have not forgotten about all of you, but it’s been a crazy year in the world of sarcomas. I’m so excited to share with you some of the highlights of ASCO, where nearly 40,000 medical oncologists and other cancer research aficionados gather yearly to present … More Updates from ASCO 2017 Annual Meeting
Greetings from Chicago, where once again, immunotherapy remains the highlight of most ASCO presentations. This year was particularly exciting, as we finally got to see the preliminary results of the first clinical trials of checkpoint inhibitors for sarcomas. So, I will update all of you on the most recent data, explain how we still have more … More Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!
In honor of the 4th of July holiday, I thought I’d squeeze in one more post – let’s talk about IMMUNOTHERAPY, which has created fireworks of its own in the cancer treatment world! In order to talk about the exciting clinical trials and ideas that are out there for sarcoma patients, we need to first … More Immunotherapy 101